Rapid Dose Therapeutics (RDT) and McMaster University partnered up on QuickStrips, vaccine strips that could revolutionize the health industry. The vaccine strips are similar to Listerine Breath Strips in that they can be ingested orally and dissolve rapidly on the tongue. The oral strips could help make vaccine delivery faster and more discreet. In preclinical trials, the vaccine strips proved effective in eliciting an immune response through the transmission of proteins into the bloodstream, which offers hope for the operationalization of this new technology.
One of the key differentiators of these new strips is their ability to be stored efficiently. While traditional vaccine vials need to be stored in cool or cold conditions, QuickStrips are stable at and above room temperature. Additionally, the vaccine strips can be self-administered, eschewing the need for supervised injections with nerve-wracking needles.
Image Credit: Rapid Dose Therapeutics
Key Themes Behind This Trend
- Oral Vaccine Delivery
- The QuickStrips offer a convenient and fast oral delivery method for vaccines, disrupting traditional injection methods.
- Non-refrigerated Vaccine Storage
- QuickStrips' stability at room temperature presents a disruption in the traditional refrigerated vaccine storage methods.
- Self-administered Vaccines
- QuickStrips' self-administered feature reduces the need for needle injections, creating opportunities for more accessible vaccine distribution.
Where This Applies
- Healthcare
- QuickStrips could revolutionize the healthcare industry by providing faster and more discreet vaccine delivery methods.
- Pharmaceuticals
- The development and production of QuickStrips offer opportunities for innovation in oral delivery vaccine technology.
- Logistics and Distribution
- QuickStrip's non-refrigerated storage feature and self-administered method present new opportunities in vaccine distribution logistics.
